SELECT id, `name`, primary_key, `key`, treemapgroup, name_cn, zacks_table_name, compare_key, compare_display_name from gurufocu_main.financial_definition where termpagedisplay=1 and `key` = 'IS_PolicyAcquisitionExpense' AZN (AstraZeneca) Policy Acquisition Expense
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Policy Acquisition Expense

AstraZeneca (AstraZeneca) Policy Acquisition Expense


View and export this data going back to 1993. Start your Free Trial

Policy Acquisition Expense only applies to insurance companies.

AstraZeneca (AstraZeneca) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Policy Acquisition Expense
Comparable Companies
LSE:GSK LLY JNJ MRK ABBV XSWX:ROG XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD TSE:4519 TSE:4568 SHSE:600276 BIIB XTER:BAYN TSE:4578 SHSE:600436 TSE:4503
Traded in Other Exchanges
AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil
Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
Website
https://www.astrazeneca.com
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.